A phase II study of gemcitabine (gemzar, LY188011) in the treatment of recurrent or persistent endometrial carcinoma: A gynecologic oncology group study

Published 2010 View Full Article

Authors

Keywords

Journal

GYNECOLOGIC ONCOLOGY

Volume 121, Issue 1, Pages 118-121

Publisher

Elsevier BV

Online

2010-12-15

DOI

10.1016/j.ygyno.2010.11.027

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

GYNECOLOGIC ONCOLOGY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Add your recorded webinar

Create your own webinar